Literature DB >> 19289088

Erbin and the NF2 tumor suppressor Merlin cooperatively regulate cell-type-specific activation of PAK2 by TGF-beta.

Mark C Wilkes1, Claire E Repellin, Min Hong, Margarita Bracamonte, Sumedha G Penheiter, Jean-Paul Borg, Edward B Leof.   

Abstract

Transforming growth factor beta (TGF-beta) family ligands are pleotropic proteins with diverse cell-type-specific effects on growth and differentiation. For example, PAK2 activation is critical for the proliferative/profibrotic action of TGF-beta on mesenchymal cells, and yet it is not responsive to TGF-beta in epithelial cells. We therefore investigated the regulatory constraints that prevent inappropriate PAK2 activation in epithelial cultures. The results show that the epithelial-enriched protein Erbin controls the function of the NF2 tumor suppressor Merlin by determining the output of Merlin's physical interactions with active PAK2. Whereas mesenchymal TGF-beta signaling induces PAK2-mediated inhibition of Merlin function in the absence of Erbin, Erbin/Merlin complexes bind and inactivate GTPase-bound PAK2 in epithelia. These results not only identify Erbin as a key determinant of epithelial resistance to TGF-beta signaling, they also show that Erbin controls Merlin tumor suppressor function by switching the functional valence of PAK2 binding.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19289088      PMCID: PMC2792748          DOI: 10.1016/j.devcel.2009.01.009

Source DB:  PubMed          Journal:  Dev Cell        ISSN: 1534-5807            Impact factor:   12.270


  46 in total

Review 1.  Rho, Rac, Pak and angiogenesis: old roles and newly identified responsibilities in endothelial cells.

Authors:  Benjamin H Fryer; Jeffrey Field
Journal:  Cancer Lett       Date:  2005-01-26       Impact factor: 8.679

2.  A role for Erbin in the regulation of Nod2-dependent NF-kappaB signaling.

Authors:  Christine McDonald; Felicia F Chen; Vincent Ollendorff; Yasunori Ogura; Sylvie Marchetto; Patrick Lécine; Jean-Paul Borg; Gabriel Nuñez
Journal:  J Biol Chem       Date:  2005-10-03       Impact factor: 5.157

Review 3.  Smad transcription factors.

Authors:  Joan Massagué; Joan Seoane; David Wotton
Journal:  Genes Dev       Date:  2005-12-01       Impact factor: 11.361

4.  Pharmacologic differentiation of inflammation and fibrosis in the rat bleomycin model.

Authors:  Nveed I Chaudhary; Andreas Schnapp; John E Park
Journal:  Am J Respir Crit Care Med       Date:  2006-01-13       Impact factor: 21.405

5.  Erbin inhibits RAF activation by disrupting the sur-8-Ras-Raf complex.

Authors:  Penggao Dai; Wen C Xiong; Lin Mei
Journal:  J Biol Chem       Date:  2005-11-21       Impact factor: 5.157

6.  Erbin regulates mitogen-activated protein (MAP) kinase activation and MAP kinase-dependent interactions between Merlin and adherens junction protein complexes in Schwann cells.

Authors:  Reshma Rangwala; Fatima Banine; Jean-Paul Borg; Larry S Sherman
Journal:  J Biol Chem       Date:  2005-01-19       Impact factor: 5.157

Review 7.  Specificity and versatility in tgf-beta signaling through Smads.

Authors:  Xin-Hua Feng; Rik Derynck
Journal:  Annu Rev Cell Dev Biol       Date:  2005       Impact factor: 13.827

8.  Transforming growth factor-beta activation of phosphatidylinositol 3-kinase is independent of Smad2 and Smad3 and regulates fibroblast responses via p21-activated kinase-2.

Authors:  Mark C Wilkes; Hugh Mitchell; Sumedha Gulati Penheiter; Jules J Doré; Kaori Suzuki; Maryanne Edens; Deepak K Sharma; Richard E Pagano; Edward B Leof
Journal:  Cancer Res       Date:  2005-11-15       Impact factor: 12.701

9.  The NF2 tumor suppressor gene product, merlin, inhibits cell proliferation and cell cycle progression by repressing cyclin D1 expression.

Authors:  Guang-Hui Xiao; Ryan Gallagher; Justin Shetler; Kristine Skele; Deborah A Altomare; Richard G Pestell; Suresh Jhanwar; Joseph R Testa
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

10.  Merlin/NF-2 mediates contact inhibition of growth by suppressing recruitment of Rac to the plasma membrane.

Authors:  Tomoyo Okada; Miguel Lopez-Lago; Filippo G Giancotti
Journal:  J Cell Biol       Date:  2005-10-24       Impact factor: 10.539

View more
  24 in total

Review 1.  Merlin: a tumour suppressor with functions at the cell cortex and in the nucleus.

Authors:  Wei Li; Jonathan Cooper; Matthias A Karajannis; Filippo G Giancotti
Journal:  EMBO Rep       Date:  2012-03       Impact factor: 8.807

2.  Identification of Erbin interlinking MuSK and ErbB2 and its impact on acetylcholine receptor aggregation at the neuromuscular junction.

Authors:  Luca Simeone; Marion Straubinger; Muhammad Amir Khan; Nancy Nalleweg; Tatiana Cheusova; Said Hashemolhosseini
Journal:  J Neurosci       Date:  2010-05-12       Impact factor: 6.167

Review 3.  The leucine-rich repeat signaling scaffolds Shoc2 and Erbin: cellular mechanism and role in disease.

Authors:  HyeIn Jang; Payton Stevens; Tianyan Gao; Emilia Galperin
Journal:  FEBS J       Date:  2020-07-06       Impact factor: 5.542

Review 4.  Signaling by the TGFβ superfamily.

Authors:  Jeffrey L Wrana
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-10-01       Impact factor: 10.005

5.  Cell type specificity of signaling: view from membrane receptors distribution and their downstream transduction networks.

Authors:  Ying He; Zhonghao Yu; Dongya Ge; Rui Wang-Sattler; Hans-Jürgen Thiesen; Lu Xie; Yixue Li
Journal:  Protein Cell       Date:  2012-07-16       Impact factor: 14.870

6.  Cell-penetrating peptides selectively targeting SMAD3 inhibit profibrotic TGF-β signaling.

Authors:  Jeong-Han Kang; Mi-Yeon Jung; Xueqian Yin; Mahefatiana Andrianifahanana; Danielle M Hernandez; Edward B Leof
Journal:  J Clin Invest       Date:  2017-05-22       Impact factor: 14.808

7.  p21-Activated kinase 2 (PAK2) inhibits TGF-β signaling in Madin-Darby canine kidney (MDCK) epithelial cells by interfering with the receptor-Smad interaction.

Authors:  Xiaohua Yan; Junyu Zhang; Qinyu Sun; Polygena T Tuazon; Xiaoping Wu; Jolinda A Traugh; Ye-Guang Chen
Journal:  J Biol Chem       Date:  2012-03-05       Impact factor: 5.157

8.  Desmoglein-1/Erbin interaction suppresses ERK activation to support epidermal differentiation.

Authors:  Robert M Harmon; Cory L Simpson; Jodi L Johnson; Jennifer L Koetsier; Adi D Dubash; Nicole A Najor; Ofer Sarig; Eli Sprecher; Kathleen J Green
Journal:  J Clin Invest       Date:  2013-03-25       Impact factor: 14.808

Review 9.  The tale of transforming growth factor-beta (TGFbeta) signaling: a soigné enigma.

Authors:  Arindam Chaudhury; Philip H Howe
Journal:  IUBMB Life       Date:  2009-10       Impact factor: 3.885

10.  FRAX597, a small molecule inhibitor of the p21-activated kinases, inhibits tumorigenesis of neurofibromatosis type 2 (NF2)-associated Schwannomas.

Authors:  Silvia Licciulli; Jasna Maksimoska; Chun Zhou; Scott Troutman; Smitha Kota; Qin Liu; Sergio Duron; David Campbell; Jonathan Chernoff; Jeffrey Field; Ronen Marmorstein; Joseph L Kissil
Journal:  J Biol Chem       Date:  2013-08-19       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.